CXCL12 and coronary artery disorder: As all these studies utilized ELISA antibodies recognizing SDF-1α without considering cleavage, the conjugated plasma levels of both active plus inactive SDF-1α (total SDF-1α) were measured, which might be responsible for the inconsistency regarding the change in ischemic heart disease and the prognostic impact of plasma SDF-1α.